Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PRMT5 is a therapeutic target in choroidal neovascularization

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.30.486275Source: DataRank Database

PRMT5 is a therapeutic target in choroidal neovascularization is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (24)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Matthew Martin ORCID,Mengyao Sun ORCID,Kamakshi Sishtla ORCID,Nathan R. Jensen,Aishat Motolani ORCID

Live enrichment

PubMed:21097893

National Institutes of Health

Grant: 5R01EY031939-03

Targeting the Ref-1 signaling node for treating ocular neovascularization

National Institutes of Health

Grant: 5R01EY025641-08

Ferrochelatase as a mediator of ocular angiogenesis

National Institutes of Health

Grant: 5R01GM120156-05

Gene-specific responses to NF-kB through lysine and arginine methylation of p65

National Institutes of Health

Grant: 5UL1TR002529-02

Indiana Clinical and Translational Sciences Institute

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2022/03/30/2022.03.30.486275.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.03.30.486275

https://doi.org/10.1101/2022.03.30.486275

https://doi.org/10.1038/s41598-023-28215-w

https://pubmed.ncbi.nlm.nih.gov/36720900

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Vascular Endothelial Growth Factor AProtein-Arginine N-Methyltransferasesmacular degenerationScienceQRNF-kappa BEndothelial CellsHydrocarbons, AromaticArticleChoroidal NeovascularizationRetinaPancreatic NeoplasmsMicePurinesMedicineAnimalsHumanspharmacologyAminesmolecular medicine

Sustainable Development Goals

SDG 3: 3. Good health